Drug composition for treating cerebral thrombosis

Abstract

The invention discloses a drug composition for treating cerebral thrombosis; the active components of the drug composition mainly comprise, by mass, 0.10-0.20 part of picrocrocin, 1.6-2.0 parts of midecamycin acetate, 0.35-0.42 parts of North America eriodictyol; the adult drug dosage is 240-260 mg active component / kg / day. The drug composition has the effects of clearing heat and promoting diuresis, invigorating the circulation of blood and detoxifying, and dispelling wind and removing obstruction in the meridians; the composition is featured by quick treatment effect and no relapse after curing specific to dizziness, nausea, sickness, diplopia, crossed akinesia and sensory disturbance, dysarthria, dysphagia, drinking choke and other symptoms caused by treating cerebral thrombosis; after long-term taking, the composition is free from obvious damage to liver and kidney, and worthy of extensive popularization and application clinically.

Description

technical field [0001] The invention relates to the field of western medicine, in particular to a pharmaceutical composition for treating cerebral thrombosis. Background technique [0002] Cerebral thrombosis is the most common type of cerebral infarction. It is the thickening of blood vessels, stenosis and occlusion of the lumen caused by atherosclerosis of the cerebral artery trunk or cortical branches, and thrombosis, resulting in reduced or interrupted blood flow in the brain, cerebral ischemia and ischemia. Oxygen leads to softening and necrosis, with signs of focal neurologic symptoms. The onset of cerebral thrombosis is generally slow, and it takes dozens of hours to several days from the onset to the peak of the disease. This disease often occurs during sleep or when resting quietly; some patients often do not have any aura symptoms before going to bed. Hemiplegia or aphasia is found when waking up, which may be related to low blood pressure and slow blood flow duri...

AI Technical Summary

Problems solved by technology

[0004] At present, Western medicines for treating cerebral thrombosis mainly include vasodilators, antihypertensive drugs and anti-platelet aggregation agents, etc. These drugs have slow curative effect and relatively large side effects.